Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poli

Showing results (1-10 of 357) with videos related to

Pageof 36
Sort By:
Pharmacological Research|March 1, 1997
Cholesterol and coronary heart disease: new data from the WOSCOP StudyA Poli
Pharmacological Research Communications|July 1, 1987
How much or how little cholesterol?A Poli
Journal - Association of Official Analytical Chemists|September 1, 1988
Laboratory procedures for detoxification of equipment and waste contaminated with brevetoxins PbTx-2 and PbTx-3M A Poli
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|April 29, 2009
[New rules on hypolipidemic drug reimbursability in Italy]R Paoletti, A Poli
Research in Veterinary Science|August 8, 2009
Simultaneous double labelling of routinely processed paraffin tissue sections using combined immunoperoxidase, immunofluorescence, and digital image editingL Ressel, A Poli
European Heart Journal|August 1, 1987
Pharmacological control of serum lipid levels: currently available drugsR Paoletti, A Poli
Giornale Italiano Di Cardiologia|September 1, 1989
[The biological bases for prevention]R Paoletti, A Poli
Cardiologia (Rome, Italy)|October 1, 1986
[Smoking and ischemic heart disease]R Paoletti, A Poli
Giornale Italiano Di Cardiologia|November 5, 1999
[Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world]A Poli, A Menotti
European Journal of Internal Medicine|September 7, 2010
Reversible and non-reversible cardiovascular risk in patients treated with lipid-lowering therapy: analysis of SEAS and JUPITER trialsA Poli, A Corsini
Pageof 36

Showing results (1-10 of 357) with videos related to

Sort By:
Pageof 36
Pharmacological Research|March 1, 1997
Cholesterol and coronary heart disease: new data from the WOSCOP StudyA Poli
Pharmacological Research Communications|July 1, 1987
How much or how little cholesterol?A Poli
Journal - Association of Official Analytical Chemists|September 1, 1988
Laboratory procedures for detoxification of equipment and waste contaminated with brevetoxins PbTx-2 and PbTx-3M A Poli
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|April 29, 2009
[New rules on hypolipidemic drug reimbursability in Italy]R Paoletti, A Poli
Research in Veterinary Science|August 8, 2009
Simultaneous double labelling of routinely processed paraffin tissue sections using combined immunoperoxidase, immunofluorescence, and digital image editingL Ressel, A Poli
European Heart Journal|August 1, 1987
Pharmacological control of serum lipid levels: currently available drugsR Paoletti, A Poli
Giornale Italiano Di Cardiologia|September 1, 1989
[The biological bases for prevention]R Paoletti, A Poli
Cardiologia (Rome, Italy)|October 1, 1986
[Smoking and ischemic heart disease]R Paoletti, A Poli
Giornale Italiano Di Cardiologia|November 5, 1999
[Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world]A Poli, A Menotti
European Journal of Internal Medicine|September 7, 2010
Reversible and non-reversible cardiovascular risk in patients treated with lipid-lowering therapy: analysis of SEAS and JUPITER trialsA Poli, A Corsini
Pageof 36